Notification of Interests in Shares
Last Updated 29 January 2026
(a) Directors and their interests
| Name of Director | Number of Ordinary Shares of 1p each |
Percent of current issued share capital |
|---|---|---|
| C.D.J. Pearce | 36,915,059 | 10.53 |
| Dr I Pike | 165,583 | 0.05 |
| Roger McDowell | 3,400,000 | 0.97 |
| Martin Diggle* | - | - |
| Richard Dennis | 2,053,571 | 0.60 |
(b) Significant Shareholders
| Name of Shareholder | Number of Ordinary Shares of 1p each |
Percent of Current issued share capital |
|---|---|---|
| Vulpes Life Science Fund | 84,932,629 | 24.2 |
| Spreadex Ltd | 10,980,386 | 3.13 |
Notes:
-The current issued share capital of the company consists of 350,724,912 Ordinary shares of 1p each. There are 39.47% of AIM securities not in public hands.
-M. Diggle is a director and partner in Vulpes Investment Management and manages the Vulpes Life Sciences Fund which is the registered holder of 24.2% of Proteome Sciences' ordinary share capital as noted above.